Investor Presentation

Ref. : PCCPL/2026-27 Date: November 4, 2026 BY E FILING The Manager The Manager Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited MUMBAI-400 001 MUMBAI-400 051 Re: BSE Scrip Code: 506618 NSE Scrip Symbol: PUNJABCHEM Sub: Investor Presentation - Financial Overview – Q2 & H1 of FY27 Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation of the Company for the second quarter and half year ended September 30, 2026. We request you to take the above information on records. Thanking you, Yours faithfully, For PUNJAB CHEMICALS AND CROP PROTECTION LIMITED RISHU CHATLEY COMPANY SECRETARY & COMPLIANCE OFFICER (ACS 19932) Encl: as above INVESTOR PRESENTATION Q2 & H1 FY27 Safe harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Punjab Chemicals and Crop Protection Ltd (the “Company’), solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company's future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cashflows, the Company's market preferences and its exposure to market risks, as well as other risks. The Company's actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections. All Maps used in the presentation are not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness PCCPL | Investor Presentation 2 Table of contents Result Highlights Company Overview Business Strategy Performance Track Record PCCPL | Investor Presentation 3 Q2 & H1 FY27 CONSOLIDATED RESULT HIGHLIGHTS Result Highlights Q2 FY27 • Registered a revenue of INR 327 Cr in Q2 FY27 growing 28% YoY and H1 FY27 at INR 674 Cr growing 17% YoY; The growth is driven by improvement in domestic sales. New products contributed 19% in Q2 FY27 growing by 295% on YoY basis ₹ 327 Cr ₹ 30 Cr ₹ 13 Cr • Gross margins stood at 34.1% for the quarter; For H1 FY27 gross margins stood at 35.4% 28.0% YoY 12.6% YoY 27.4% YoY • EBITDA for Q2FY27 stands at INR 30 Cr with a margin of 9%. For H1 Revenue EBITDA PAT FY27 EBITDA stood at INR 72 Cr with a margin of 11% fueled by operational efficiencies and a refined product portfolio • Profit After Tax for the quarter stood at INR 13 Cr with a margin of 4.1%. For H1 FY27, PAT stood at 36 Cr with a margin of 5.3% • New Products: Capacity enhancement for new intermediates for H1 FY27 Agro intermediate successfully commercialized with more efficient process and volume growth is expected to be 100% in current financial year • Strategic Partnership: Commercial lot supplied for 2 of the 3 MoU products. Volume pick up will start from Q4FY27 onwards • Domestic Market Expansion: 2 intermediate herbicide products launch planned in Q3/Q4FY27 ₹ 674 Cr ₹ 72 Cr ₹ 36 Cr 17.3% YoY 19.3% YoY 9.3% YoY Revenue EBITDA PAT PCCPL | Investor Presentation 5 Q2 FY27 Financial performance REVENUE GEOGRAPHICAL SPLIT +28% +28% 327 327 255 255 Domestic 116 International 139 141 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 EBITDA & EBITDA MARGIN PAT & PAT MARGIN 10.3% 9.0% 7.3% 4.1% +13% 30 -27% Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 All figures in INR Cr PCCPL | Investor Presentation 6 H1 FY27 Financial performance REVENUE GEOGRAPHICAL SPLIT +17% +17% 674 674 575 575 Domestic 312 International 262 298 H1 FY26 H1 FY27 H1 FY26 H1 FY27 EBITDA & EBITDA MARGIN PAT & PAT MARGIN 10.5% 10.7% 6.8% 5.3% +19% 72 -9% 61 39 H1 FY26 H1 FY27 H1 FY26 H1 FY27 All figures in INR Cr PCCPL | Investor Presentation 7 Consolidated Profit & Loss Statement Particulars (In Rs Cr) Q2 FY27 Q2 FY26 YoY % Q1 FY27 QoQ % H1 FY27 H1 FY26 YoY % Revenue 326.7 255.2 28.0% 347.2 -5.9% 673.9 574.7 17.3% COGS 215.4 154.4 220.1 435.5 368.3 Gross Profit 111.3 100.8 127.1 238.4 206.4 Gross Margin % 34.1% 39.5% 36.6% 35.4% 35.9% Employee Expenses 28.0 25.7 34.1 62.1 50.5 Other Expenses 53.8 48.8 52.2 104.0 95.3 EBITDA 29.6 26.2 12.6% 40.8 -27.5% 72.3 60.6 19.3% EBITDA Margin % 9.0% 10.3% 11.8% 10.7% 10.5% Depreciation 8.0 6.6 7.3 15.3 13.2 Finance Cost 5.7 3.8 4.1 9.8 7.7 Other Income 2.4 6.1 0.7 1.1 9.8 Profit before exceptional items and tax 18.3 21.9 -16.4% 30.1 -39.2% 48.3 49.5 -2.3% Exceptional Item - - - - - Profit before Tax 18.3 21.9 30.1 48.3 49.5 Tax Expense 4.8 3.4 8.0 12.8 10.3 Profit after Tax 13.5 18.5 -27.4% 22.1 -39.0% 35.5 39.2 -9.3% PAT Margin % 4.1% 7.3% 6.4% 5.3% 6.8% EPS (in Rs.) 11.0 15.1 18.0 29.0 32.0 PCCPL | Investor Presentation 8 Consolidated Balance Sheet Statement Particulars (In Rs Cr.) Sep’26 Mar’26 Particulars (In Rs Cr.) Sep’26 Mar’26 EQUITY AND LIABLITIES ASSETS Equity Non-Current Assets Equity Share Capital 12.3 12.3 Property, Plant and Equipment 267.9 255.5 Other Equity 443.3 411.2 Capital Work in Progress 15.3 17.5 Total Equity 455.6 423.5 Right of Use Assets 13.6 15.9 Non-Current Liabilities Intangible Assets 2.8 3.5 Financial Liabilities Intangible Assets Under Development 1.2 1.3 Borrowings 71.7 37.4 Financial Assets: Lease Liabilities 7.1 8.3 Investments 1.7 1.7 Other Financial Liabilities 2.0 2.3 Others 5.4 5.1 Provisions 5.2 4.5 Other Tax Assets (net) 1.6 13.2 Deferred Tax Liabilities 12.8 12.0 Other Non-Current Assets 6.0 0.1 Total Non-Current Liabilities 98.8 64.5 Total Non-Current Assets 315.5 313.8 Current Liabilities Current Assets Financial Liabilities Inventories 213.2 245.8 Borrowings 212.8 105.0 Financial Assets: Lease Liabilities 3.8 3.5 Investments - Trade Payables Trade Receivables 453.9 203.5 (i) Total Outstanding dues of MSME 27.9 20.7 Cash & Bank Balances 9.9 8.7 (ii) Total Outstanding dues of Creditors other than MSME 189.0 152.2 Bank balances other than iii. Above 8.2 6.3 Other Financial Liabilities 36.2 35.7 Loans 0.3 0.2 Other Current Liabilities 6.2 4.5 Provisions 7.3 5.4 Other Financial Assets 22.8 12.4 Current Tax Liabilities (net) 10.9 8.0 Other Current [Showing first 8,000 characters — download PDF for full document]